BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25731019)

  • 41. Molecular biology, virulence, and pathogenicity of mycobacteria.
    Shinnick TM; King CH; Quinn FD
    Am J Med Sci; 1995 Feb; 309(2):92-8. PubMed ID: 7847448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidation of the Mycobacterium tuberculosis key virulence factor protein tyrosine phosphatase A (MptpA) reduces its phosphatase activity.
    Niesteruk A; Sreeramulu S; Jonker HRA; Richter C; Schwalbe H
    FEBS Lett; 2022 Jun; 596(12):1503-1515. PubMed ID: 35397176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional responses of Mycobacterium tuberculosis exposed to adverse conditions in vitro.
    Bacon J; Marsh PD
    Curr Mol Med; 2007 May; 7(3):277-86. PubMed ID: 17504112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium tuberculosis in the post-genomic age.
    Domenech P; Barry CE; Cole ST
    Curr Opin Microbiol; 2001 Feb; 4(1):28-34. PubMed ID: 11173030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a putative ArsR transcriptional regulator encoded by Rv2642 from Mycobacterium tuberculosis.
    Li Q; Li C; Xie L; Zhang C; Feng Y; Xie J
    J Biomol Struct Dyn; 2017 Jul; 35(9):2031-2039. PubMed ID: 27353442
    [No Abstract]   [Full Text] [Related]  

  • 46. A high-frequency single nucleotide polymorphism in the MtrB sensor kinase in clinical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties.
    Waturuocha UW; P J A; Singh KK; Malhotra V; Krishna MS; Saini DK
    PLoS One; 2021; 16(9):e0256664. PubMed ID: 34529706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C-terminal domain of the virulence factor MgtC is a divergent ACT domain.
    Yang Y; Labesse G; Carrère-Kremer S; Esteves K; Kremer L; Cohen-Gonsaud M; Blanc-Potard AB
    J Bacteriol; 2012 Nov; 194(22):6255-63. PubMed ID: 22984256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors.
    Onwueme KC; Vos CJ; Zurita J; Soll CE; Quadri LE
    J Bacteriol; 2005 Jul; 187(14):4760-6. PubMed ID: 15995190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection.
    Italia A; Shaik MM; Peri F
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The netural red test: a method of determining virulence of mycobacteria.
    JEFFERIES MB; SCHNEIDER NJ; HARDY AV
    U S Armed Forces Med J; 1960 Aug; 11():927-31. PubMed ID: 14406996
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparatives studies on virulence and pathogenicity of Mycobacterium tuberculosis in vivo and in vitro].
    HENEBERG D; BOGDANOV L
    Vojnosanit Pregl; 1954; 11(11-12):588-93. PubMed ID: 14374275
    [No Abstract]   [Full Text] [Related]  

  • 52. [Present state of the problem of virulence of Mycobacterium tuberculosis; review of foreign periodical literature].
    PROZOROV AA
    Sovrem Probl Tuberk; 1956; 7(3):9-18. PubMed ID: 13351962
    [No Abstract]   [Full Text] [Related]  

  • 53. [Research on vitality and pathogenicity of Mycobacterium tuberculosis].
    SIMON M; BERENCSI G
    Borgyogy Venerol Sz; 1955 May; 9(3):75-8. PubMed ID: 13250043
    [No Abstract]   [Full Text] [Related]  

  • 54. [Considerations on the problem of virulence of Mycobacterium tuberculosis].
    JANKOV M
    Vojnosanit Pregl; 1959 Jan; 16(1):36-41. PubMed ID: 13648128
    [No Abstract]   [Full Text] [Related]  

  • 55. A modification of virulence of Mycobacterium tuberculosis by chick embryo adaptation.
    HSIUNG GD; HALEY LD
    Am Rev Tuberc; 1956 Aug; 74(2 Part 1):249-57. PubMed ID: 13340153
    [No Abstract]   [Full Text] [Related]  

  • 56. Identifying mycobacterium tuberculosis virulence determinants - new technologies for a difficult problem: response.
    Graham JE; Clark-Curtiss JE
    Trends Microbiol; 2000 Mar; 8(3):100. PubMed ID: 10707057
    [No Abstract]   [Full Text] [Related]  

  • 57. PRESENT CONCEPTIONS OF RENAL TUBERCULOSIS.
    McClelland JC
    Can Med Assoc J; 1933 Nov; 29(5):514-20. PubMed ID: 20319296
    [No Abstract]   [Full Text] [Related]  

  • 58. Some Aspects of the Tuberculosis Problem from the Experimental and Comparative Standpoint.
    Smith T
    Edinb Med J; 1924 Mar; 31(3):176-181. PubMed ID: 29647799
    [No Abstract]   [Full Text] [Related]  

  • 59. Tuberculosis Schemes.
    Ind Med Gaz; 1931 Sep; 66(9):522-523. PubMed ID: 29010028
    [No Abstract]   [Full Text] [Related]  

  • 60. A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics.
    Wlodarska M; Johnston JC; Gardy JL; Tang P
    Clin Microbiol Rev; 2015 Apr; 28(2):523-39. PubMed ID: 25810419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.